Stock Analysis
Fortrea Holdings Inc. (FTRE) Stock Analysis
Fortrea Holdings Inc. (FTRE) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Fortrea Holdings Inc. (FTRE) currently has an AIQ Score of 75/100, indicating a bullish setup. Value is the strongest factor at 93/100. Risk is the weakest current factor at 41/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
FTRE at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $20.20 |
| AIQ Score | 75/100 |
| Overall View | Bullish |
| Technical Analysis Consensus | Sell |
| Market Cap | $1.93B |
| P/E Ratio (TTM) | -26.8 |
| Forward P/E | — |
| EPS (Q3 FY2026) | $0.01 |
| Revenue (Q3 FY2026) | $691.5M |
| Dividend Yield (TTM) | 0.00% |
| Beta | 1.62 |
| Volume | 1.96M |
| 52-week range | $8.55-$26.16 |
| RSI 14 | 43.47 |
| 50-Day SMA | $20.76 |
| 200-Day SMA | $15.90 |
| Analyst Price Target | $24.75 |
| Next Earnings | Feb 25, 2027 |
FTREFortrea Holdings Inc.
Healthcare / Biotechnology
Leader
Strong Relative Position
Latest quote
- Momentum88
- Value93
- Quality65
- Risk resilience41
- Sentiment—
FTRE Stock Analysis Summary
Fortrea Holdings Inc. (FTRE) currently has an AIQ Score of 75/100, indicating a bullish setup. Value is the strongest factor at 93/100. Risk resilience is the weakest current factor at 41/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a bullish regime, FTRE has AIQ Score of 75/100 with Value base of 93/100 and fading Risk resilience at 41/100. Wait for component alignment before adding exposure.
Value (93/100) leads while Risk resilience (41/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · 0.70% stock move · FTRE classified in Biotechnology.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is FTRE Bullish or Bearish Right Now?
FTRE currently has a bullish overall setup. Value is the strongest factor at 93/100, while Risk Resilience is weakest at 41/100. The current evidence suggests a constructive setup.
- - Quality is supportive at 65/100.
- - Momentum is constructive at 88/100.
- - Analyst target implies +22.52% upside from the latest quote.
- - Risk Resilience is weak at 41/100.
- - Technical consensus has more sell votes than buy votes (31 vs 12).
Current Consensus
FTRE's Technical Analysis Consensus is currently Sell, with 12 buy, 3 neutral, and 31 sell votes. FTRE's 14-day RSI is 43.47, which places the stock in a weaker momentum range. FTRE's beta is 1.62, indicating greater market sensitivity than the broad market.
What Changed in FTRE?
The largest recent change in FTRE is AIQ Score moving up by 1.0 points over the available 7-day comparison window. Value remains the strongest visible factor.
What Would Change the FTRE Outlook?
The current bullish outlook could improve if AIQ reaches 65 (Bullish), momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 50 (Bearish), price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ 65+ (Bullish), RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 50 (Bearish), RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
FTRE Decision Framework
Public evidence layers, setup checks, and risk context for Fortrea Holdings Inc..
Fortrea Holdings Inc. (FTRE) Stock Analysis
Fortrea Holdings Inc. has an AIQ Score of 75/100 in a Bullish regime. Value is strongest at 93/100. Beta is 1.62, above market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | FTRE is in a Bullish AIQ regime with score 75/100. |
| Signal Conflict | The primary conflict is that value leads at 93/100 while risk lags at 41/100. |
| Factor Evidence | Momentum 88/100 · Value 93/100 · Quality 65/100 · Risk 41/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Value is the strongest factor at 93/100.
Momentum is 88/100 and RSI (14) is 43.5.
FTRE is in a Bullish regime at 75/100.
Risk factor is 41/100 with beta 1.62 and annual volatility 67.32%.
Current conflict: value leads at 93/100 while risk lags at 41/100.
FTRE Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
FTRE Fundamentals
FTRE valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
FTRE Technical Analysis
FTRE technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
FTRE Stock Catalysts
Track FTRE earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
FTRE Dividend Analysis
FTRE dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
FTRE Financial Data
FTRE revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
FTRE Risk Analysis
FTRE volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
FTRE Stock News
FTRE stock news, market tone, recent headlines, and catalyst context.
FTRE vs Biotechnology Peers
Current peer cohort: FTRE · GMAB · HALO · HRMY · IDYA. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| FTRE Current stock | 75/100 | 93/100 | 88/100 | 41/100 | 1.29 | 67.32% | Current |
| GMAB Genmab A/S | 77/100 | 71/100 | 94/100 | 58/100 | 1.29 | 45.85% | FTRE vs GMAB |
| HALO Halozyme Therapeutics, Inc. | 78/100 | 76/100 | 84/100 | 63/100 | 0.95 | 41.04% | FTRE vs HALO |
| HRMY Harmony Biosciences Holdings, Inc. | 73/100 | 89/100 | 66/100 | 63/100 | 0.07 | 40.59% | FTRE vs HRMY |
| IDYA IDEAYA Biosciences, Inc. | 54/100 | 39/100 | 63/100 | 61/100 | 0.14 | 44.94% | FTRE vs IDYA |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Nov 13, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
Also for FTRE: historical return with reinvested dividends and stock average calculator for several buys.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Nov 16, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Sep 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching FTRE
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for FTRE
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
FTRE Stock FAQ
What is FTRE stock price today?
Fortrea Holdings Inc.'s current stock price is $20.20. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is FTRE bullish or bearish right now?
FTRE's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is FTRE's market cap?
FTRE's market cap is $1.93B based on the latest completed market-close snapshot from Nov 13, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is FTRE's current P/E ratio?
FTRE's current P/E ratio is -26.8 based on the latest completed market-close snapshot from Nov 13, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is FTRE's RSI?
FTRE's 14-day RSI is 43.47 based on the latest completed market-close snapshot from Nov 13, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is FTRE above its 50-day and 200-day moving averages?
FTRE is -2.71% from its 50-day SMA and 27.03% from its 200-day SMA based on the latest completed market-close snapshot from Nov 13, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is FTRE's next earnings date?
FTRE's next earnings date is currently listed as Feb 25, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does FTRE pay a dividend?
FTRE's dividend yield is 0.00% based on the latest completed market-close snapshot from Nov 13, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.